GHK-Cu
Copper Peptide Complex
Naturally occurring copper complex of the tripeptide Gly-His-Lys. Studied for stimulation of collagen and glycosaminoglycan synthesis, activation of anti-aging gene expression, and support of dermal regeneration and wound healing.
Format
50mg / vial
Purity
>99.6%
Category
Longevity
Storage
2–8 °C
Research Price
€79
50mg / vial
RESEARCH USE ONLY
This compound is sold exclusively for in-vitro laboratory research. It is not intended for human consumption, therapeutic use, or self-administration. You must be 18+ and a qualified researcher to purchase.
Complete Your Research with the Pen Kit
Precise, painless, repeatable. The clinical-grade injection pen with 32G ultra-fine needles, bacteriostatic water, and your choice of peptide — ready to use out of the box.
€189
View details →Research Protocol Bundles
Recovery Stack
BPC-157 + TB-500 + GHK-Cu
The gold-standard soft-tissue repair protocol. Combines systemic repair (TB-500), localised healing (BPC-157), and skin/collagen regeneration (GHK-Cu) into a synergistic three-compound cycle.
Bundle total
€262
10% bundle saving
Documented Research Parameters
Research Dose
1–2 mg
Frequency
Daily or every other day
Duration
6–12 weeks
Half-Life
~0.5–1 hour
Route(s)
Subcutaneous · Topical (research formulations)
Solubility
Water (blue solution)
Reconstitution
2 ml bacteriostatic water per 50 mg vial (for injectable research). Topical: dissolve in appropriate carrier.
Key Research Findings
Activates over 4,000 genes involved in tissue remodelling, anti-inflammatory response, and antioxidant defence.
Stimulates collagen I, III, and IV synthesis in fibroblast models.
Demonstrated hair follicle stimulation and increased density in dermal studies.
Blue colour when dissolved indicates intact copper chelation — expected and correct.
Administration Reference
In injectable research protocols, subcutaneous administration is standard. For systemic research, abdominal subcutaneous sites are commonly used. For site-specific research (e.g. dermal or scalp studies), local injection proximate to the area of interest has been explored. Topical research formulations require an appropriate penetration-enhancing vehicle (e.g. DMSO, liposomal base).
Documented Combination Protocols
Complementary tissue repair signalling — GHK-Cu drives collagen, BPC-157 modulates systemic inflammation.
Synergistic wound-healing cascade: angiogenesis (TB-500) + matrix remodelling (GHK-Cu).
Combined anti-aging signalling: GHK-Cu for dermal regeneration, Epithalon for telomere biology.
IMPORTANT RESEARCH DISCLAIMER
This compound is for in-vitro research and laboratory use only. It has not been evaluated or approved by any regulatory authority for human therapeutic use. It must not be used as a food, drug, or cosmetic. SYNTHEXA assumes no liability for misuse. Handle in accordance with Good Laboratory Practice.